|
1
|
Muller M, Schouten RD, De Gooijer CJ and
Baas P: Pembrolizumab for the treatment of non-small cell lung
cancer. Expert Rev Anticancer Ther. 17:399–409. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bremnes RM, Donnem T and Busund LT:
Importance of tumor infiltrating lymphocytes in non-small cell lung
cancer? Ann Transl Med. 4:1422016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Planchard D, Popat S, Kerr K, Novello S,
Smit EF, Faivre-Finn C, Mok TS, Reck M, Van Schil PE, Hellmann MD,
et al: Metastatic non-small cell lung cancer: ESMO clinical
practice guidelines for diagnosis, treatment and follow-up. Ann
Oncol. 29 (Suppl 4):iv192–iv237. 2018. View Article : Google Scholar
|
|
6
|
Hong L, Sun H, Lv X, Yang D, Zhang J and
Shi Y: Expression of periostin in the serum of NSCLC and its
function on proliferation and migration of human lung
adenocarcinoma cell line (A549) in vitro. Mol Biol Rep.
37:2285–2293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Favara MT, Aghai Z, Gayen nee' Betal S,
Fong G and Addya S: Effects of chorioamnionitis on microRNA profile
in cord blood mononuclear leukocytes. Pediatrics. 144:6312019.
|
|
8
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Catalanotto C, Cogoni C and Zardo G:
MicroRNA in control of gene expression: An overview of nuclear
functions. Int J Mol Sci. 17:17122016. View Article : Google Scholar
|
|
10
|
Di Leva G, Garofalo M and Croce CM:
microRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Leonetti A, Assaraf YG, Veltsista PD, El
Hassouni B, Tiseo M and Giovannetti E: MicroRNAs as a drug
resistance mechanism to targeted therapies in EGFR-mutated NSCLC:
Current implications and future directions. Drug Resist Updat.
42:1–11. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen W, Wang J, Liu S, Wang S, Cheng Y,
Zhou W, Duan C and Zhang C: MicroRNA-361-3p suppresses tumor cell
proliferation and metastasis by directly targeting SH2B1 in NSCLC.
J Exp Clin Cancer Res. 35:762016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang J, Sun C, Wang S, He Q and Li D:
microRNA miR-10b inhibition reduces cell proliferation and promotes
apoptosis in non-small cell lung cancer (NSCLC) cells. Mol Biosyst.
11:2051–2059. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song L, Li D, Gu Y, Wen ZM, Jie J, Zhao D
and Peng LP: MicroRNA-126 targeting PIK3R2 inhibits NSCLC A549 cell
proliferation, migration, and invasion by regulation of
PTEN/PI3K/AKT pathway. Clin Lung Cancer. 17:e65–e75. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun C, Li S, Yang C, Xi Y, Wang L, Zhang F
and Li D: MicroRNA-187-3p mitigates non-small cell lung cancer
(NSCLC) development through down-regulation of BCL6. Biochem
Biophys Res Commun. 471:82–88. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Wang X, Wu G, Hou D and Hu Q:
MiR-365b-3p, down-regulated in retinoblastoma, regulates cell cycle
progression and apoptosis of human retinoblastoma cells by
targeting PAX6. FEBS Lett. 587:1779–1786. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tian Q, Sun HF, Wang WJ, Li Q, Ding J and
Di W: miRNA-365b promotes hepatocellular carcinoma cell migration
and invasion by downregulating SGTB. Future Oncol. 15:2019–2028.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Amable L, Grankvist N, Largen JW, Ortsäter
H, Sjöholm Å and Honkanen RE: Disruption of serine/threonine
protein phosphatase 5 (PP5:PPP5c) in mice reveals a novel role for
PP5 in the regulation of ultraviolet light-induced phosphorylation
of serine/threonine protein kinase Chk1 (CHEK1). J Biol Chem.
286:40413–40422. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng L, Sun P, Li Z, Liu M and Sun S:
Knockdown of PPP5C inhibits growth of hepatocellular carcinoma
cells in vitro. Appl Biochem Biotechnol. 175:526–534. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng X, Zhang L, Jin B, Zhang F, Zhang D
and Cui L: Knockdown of protein phosphatase 5 inhibits ovarian
cancer growth in vitro. Oncol Lett. 11:168–172. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu J, Ji Y, Yu Y, Jin Y, Zhang X, Zhou J
and Chen Y: Knockdown of serine/threonine protein phosphatase 5
enhances gemcitabine sensitivity by promoting apoptosis in
pancreatic cancer cells in vitro. Oncol Lett. 15:8761–8769.
2018.PubMed/NCBI
|
|
22
|
Grankvist N, Amable L, Honkanen RE,
Sjöholm A and Ortsäter H: Serine/threonine protein phosphatase 5
regulates glucose homeostasis in vivo and apoptosis signalling in
mouse pancreatic islets and clonal MIN6 cells. Diabetologia.
55:2005–2015. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen YL, Hung MH, Chu PY, Chao TI, Tsai
MH, Chen LJ, Hsiao YJ, Shih CT, Hsieh FS and Chen KF: Protein
phosphatase 5 promotes hepatocarcinogenesis through interaction
with AMP-activated protein kinase. Biochem Pharmacol. 138:49–60.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mazalouskas MD, Godoy-Ruiz R, Weber DJ,
Zimmer DB, Honkanen RE and Wadzinski BE: Small G proteins Rac1 and
Ras regulate serine/threonine protein phosphatase 5
(PP5)·extracellular signal-regulated kinase (ERK) complexes
involved in the feedback regulation of Raf1. J Biol Chem.
289:4219–4232. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peng Y and Croce CM: The role of MicroRNAs
in human cancer. Signal Transduct Target Ther. 1:150042016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lv JM, Chen L, Gao Y, Huang H, Pan XW, Liu
X, Chen M, Qu FJ, Li L, Wang JK, et al: PPP5C promotes cell
proliferation and survival in human prostate cancer by regulating
of the JNK and ERK1/2 phosphorylation. Onco Targets Ther.
11:5797–5809. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xie J, Han M, Zhang M, Deng H and Wu W:
PP5 (PPP5C) is a phosphatase of Dvl2. Sci Rep. 8:27152018.
View Article : Google Scholar : PubMed/NCBI
|
